AI adoption in pharma.Faster cycles. Lighter documentation burden. No compliance risk
Pharmaceutical organizations carry one of the heaviest documentation loads of any industry. Regulatory submissions, SOPs, clinical trial records, quality reports. GenAI can accelerate all of it. But in a GxP environment, adoption cannot outpace governance. Mendo is built for that constraint.
Pharma's documentation burden is the first AI opportunity
Governance that meets your standards
Mendo runs inside your approved environments — Copilot 365 or ChatGPT Enterprise — within the compliance perimeter already validated by your QA and IT teams. No data leaves your infrastructure. No shadow AI.
Less time on regulatory overhead
SOP drafting, submission summaries, quality deviation reports, audit preparation, clinical study synopses. Mendo's labs target the documentation tasks that consume the most expert time.
Mendo Coach Agent
An AI-powered proactive coach available inside M365 to guide users in real time.
Less drafting. More science
Regulatory and medical affairs experts are scarce. Mendo takes care of structuring, summarizing, and drafting, so your best people focus on scientific judgment, not document assembly
2,8x
higher adoption rate
40%
of users deploy a business use case
Platform
How it works
Embedded in your existing tools. Continuous, measurable, built for the pace of retail.
Line
Map readiness across functions and sites
Mendo starts with a readiness assessment by function — regulatory affairs, medical affairs, clinical operations, quality, commercial. Identify where GenAI adoption creates immediate value and where compliance requirements demand a more careful approach.
Target expert time lost to documentation
Regulatory affairs teams accelerate submission summaries and variation dossiers. Quality teams structure deviation reports and CAPA documentation. Medical affairs draft scientific synopses and internal briefings. Everything runs inside Copilot 365 or ChatGPT Enterprise. No new system, no validation project.
Embed responsible use into every learning path
In pharma, AI outputs carry scientific and regulatory weight. Mendo builds critical review into the adoption journey — teams learn to use AI as a drafting and synthesis layer, while retaining full ownership of the content they sign off on.
Track adoption and ROI across the organization
Track activation, deployed use cases, and expert time recovered, by function and geography. Every step is visible and reportable to your CDO, Head of Regulatory Affairs, and executive committee.
testimonials
How organizations turn GenAI into impact
Line
"Mendo had a real differentiator with its lab approch, with formats of 3 to 10 minutes which allows, within this lab, to discover a concept or skill applied to a usage, often directly related to the profession."
Rémi Moniot, Digital innovation director
5% to 80% Recurring use case adoption
"Gen. AI is transforming our businesses, it is essential to support our teams in the adoption of these new uses and the development of new skills.
We chose the solution proposed by Mendo, which met our challenges in every way.
This initiative aims to make AI an asset for competitiveness"
Aurélia Le Baudour, Head of Innovation and Digital Transformation
NPS: 60
60%users use Copilot >3 days a week
"The main advantage of Mendo is that we really learn by doing."
Sandrine Delmas, Quality Director
x3the number of prompts sent
5use cases identified / user
FAQ
Common questions
Line
Does Mendo require a separate validation project under GxP requirements?
No. Mendo deploys inside Copilot 365 or ChatGPT Enterprise — tools that are already part of your validated or approved infrastructure. There is no new system to qualify. Your IT and QA teams work within the compliance perimeter they already manage.
How does Mendo protect proprietary research data and IP?
Mendo does not process or store any proprietary data on external servers. All interactions remain within your M365 or enterprise AI environment, subject to the same data governance policies already in place. No data is used to train third-party models.
Which functions should start with Mendo in a pharma organization?
Regulatory Affairs, Medical Affairs, and Quality are typically the highest-ROI starting points. The documentation burden is highest there, and the compliance framework is already strong enough to absorb AI adoption without additional risk. Commercial and support functions can follow in parallel.
How does Mendo handle the requirement that AI outputs be reviewed and owned by qualified professionals?
That requirement is built into the adoption model. Mendo positions AI as a drafting and synthesis layer, not a decision-making system. Every learning path reinforces that professionals retain full ownership and sign-off responsibility for the content they produce with AI assistance.
How quickly can we expect measurable results?
For Regulatory Affairs and Medical Affairs, first use cases typically emerge within 30 days. Most clients reach 80% weekly active users across deployed functions within 6 months. We provide a deployment plan calibrated to your function priorities and compliance requirements at onboarding.
Let's get started !
Creating the foundations for human–AI collaboration
Mendo helps organizations drive high-quality GenAI adoption, measure impact, and prepare teams for agentic workflows.
